Gain Therapeutics Ownership | Who Owns Gain Therapeutics?


OverviewForecastRevenueFinancialsChart

Gain Therapeutics Ownership Summary


Gain Therapeutics is owned by 16.89% institutional investors, 5.09% insiders, and 78.02% retail investors. Dme capital management, lp is the largest institutional shareholder, holding 3.15% of GANX shares. Fidelity Extended Market Index is the top mutual fund, with 0.57% of its assets in Gain Therapeutics shares.

GANX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGain Therapeutics16.89%5.09%78.02%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Dme capital management, lp566.13K3.15%$724.65K
Hohimer wealth management330.00K1.84%$422.40K
Geode capital management183.74K1.02%$235.22K
Vanguard group145.22K0.81%$185.88K
Renaissance118.70K0.66%$151.94K
Blackrock84.62K0.47%$108.31K
Northern trust44.94K0.25%$57.53K
Bridgeway capital management40.00K0.22%$51.20K
Prelude capital management35.82K0.20%$45.85K
State street34.44K0.19%$44.08K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Hohimer wealth management330.00K0.10%$422.40K
Dme capital management, lp566.13K0.04%$724.65K
Prelude capital management35.82K0.00%$45.85K
Virtu financial27.36K0.00%$35.00K
Creekmur asset management4.44K0.00%$5.68K
Bridgeway capital management40.00K0.00%$51.20K
Renaissance118.70K0.00%$151.94K
Tower research capital llc (trc)1.73K-$2.21K
Blackrock84.62K-$108.31K
Timelo investment management---

Top Buyers

HolderShares% AssetsChange
Hohimer wealth management330.00K0.10%330.00K
Renaissance118.70K0.00%72.00K
Virtu financial27.36K0.00%27.36K
Vanguard group145.22K-25.85K
Bridgeway capital management40.00K0.00%10.00K

Top Sellers

HolderShares% AssetsChange
Timelo investment management---605.29K
Alyeska investment group---450.00K
Raymond james & associates---260.02K
Royal bank of canada---248.50K
Cable car capital---145.00K

New Positions

HolderShares% AssetsChangeValue
Hohimer wealth management330.00K0.10%330.00K$422.40K
Virtu financial27.36K0.00%27.36K$35.00K
Jones financial companies lllp7.00K-7.00K$8.96K

Sold Out

HolderChange
Newedge advisors-225.00
Citigroup-684.00
Hm payson-1.00K
Citadel advisors-2.50K
Gilbert & cook-10.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202427-10.00%3,036,72262.60%1612.72%1820.00%5-28.57%
Mar 31, 20243015.38%1,867,61520.86%117.79%1536.36%716.67%
Dec 31, 202326-1,545,2471.96%128.13%11-8.33%620.00%
Sep 30, 202326-3.70%1,515,52319.55%1210.84%12-14.29%525.00%
Jun 30, 20232712.50%1,267,72210.29%1011.45%1455.56%4-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index146.74K0.57%62.19K
Vanguard Institutional Extnd Mkt Idx Tr135.70K0.53%-
Fidelity Total Market Index56.81K0.22%-
Bridgeway Ultra-Small Company Market40.00K0.16%10.00K
iShares Micro-Cap ETF38.78K0.15%-
BlackRock Extended Equity Market K36.53K0.14%-16.00
Fidelity Series Total Market Index33.88K0.13%18.95K
Spartan Extended Market Index Pool E17.63K0.07%7.10K
Northern Trust Extended Eq Market Idx15.62K0.06%-
NT Ext Equity Mkt Idx Fd - L15.62K0.06%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 09, 2024Mack Gene CFO and Interim CEOBuy$14.54K
Aug 09, 2024Islam Khalid Executive ChairmanBuy$49.94K
Jul 01, 2024RICHMAN ERIC I-Buy$14.52K
Jul 01, 2024RICHMAN ERIC I-Buy$6.15K
Mar 28, 2024Riley Jeffrey Scott-Buy$115.77K

Insider Transactions Trends


DateBuySell
2024 Q32-
2024 Q2--
2024 Q11-
2023 Q4-2
2023 Q3--

GANX Ownership FAQ


Who Owns Gain Therapeutics?

Gain Therapeutics shareholders are primarily institutional investors at 16.89%, followed by 5.09% insiders and 78.02% retail investors. The average institutional ownership in Gain Therapeutics's industry, Biotech Stocks , is 45.43%, which Gain Therapeutics falls below.

Who owns the most shares of Gain Therapeutics?

Gain Therapeutics’s largest shareholders are Dme capital management, lp (566.13K shares, 3.15%), Hohimer wealth management (330K shares, 1.84%), and Geode capital management (183.74K shares, 1.02%). Together, they hold 6.01% of Gain Therapeutics’s total shares outstanding.

Does Blackrock own Gain Therapeutics?

Yes, BlackRock owns 0.47% of Gain Therapeutics, totaling 84.62K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 108.31K$. In the last quarter, BlackRock increased its holdings by 9.22K shares, a 12.23% change.

Who is Gain Therapeutics’s biggest shareholder by percentage of total assets invested?

Hohimer wealth management is Gain Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 330K Gain Therapeutics shares, valued at 422.4K$.

Who is the top mutual fund holder of Gain Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Gain Therapeutics shares, with 0.57% of its total shares outstanding invested in 146.74K Gain Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools